International Journal of Cancer Management

The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences

e-ISSN 2538-497X

p-ISSN 2538-4422

Citation data

Scopus by Title (Ref)

Articles that cite the referenced work, matched by title from the Scopus database.

8 resultsUpdated September 16, 2026

← Back to article

1

New Substituted 6,7-Dimethoxy-N-phenyl-2-(piperazin-1-yl)quinazolin-4-amine Derivatives: Synthesis, Characterization, Cytotoxicity against SKBR3 and Trastuzumab Resistance SKBR3 Cell Lines, and EGFR/HER2 Dual Kinase Inhibition Assay

Chemical Methodologies

October 2025

Bakshi V.

2

Exploring Bevacizumab's Role in Gynecological Cancers: An Up-to-Date Narrative Review Focusing on Ovarian Cancer

Materia Socio Medica

2024

Liolis E.

All Open Access, Green

3

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody

Frontiers in Immunology

2023

Bai Y.

Open Access

4

Anti-drug antibodies in the current management of cancer

Cancer Chemotherapy and Pharmacology

May 2022

Borregón M.

5

Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences

Indian Journal of Medical Research

March-April 2022

Saffari F.

Open Access

6

Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis

CNS Drugs

September 2021

Bar-Or A.

Open Access

7

Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to Bedside

Journal of Pharmaceutical Sciences

July 2021

Bray-French K.

Open Access

8

The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies

Frontiers in Immunology

18 August 2020

Vaisman-Mentesh A.

Open Access